You just read:

Nektar Presents New Clinical Data from Two Studies of NKTR-214, a CD122-Biased Agonist, at 2017 American Society of Clinical Oncology (ASCO) Annual Meeting

News provided by

Nektar Therapeutics

05 Jun, 2017, 09:00 ET